Cyren (CYRNQ) 20-F 30 Apr 15 2014 FY Annual report (foreign) Financial data

Document_And_Entity_Informatio

Document And Entity Information	12 Months Ended
	Dec. 31, 2014
Document And Entity Information [Abstract]
Document Type	20-F
Amendment Flag	FALSE
Document Period End Date	31-Dec-14
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY
Entity Registrant Name	CYREN Ltd.
Entity Central Index Key	1084577
Current Fiscal Year End Date	-19
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Common Stock, Shares Outstanding	31,396,940

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
CURRENT ASSETS:
Cash and cash equivalents	$11,063	$3,757
Trade receivables, net	4,444	5,178
Deferred tax assets		48
Prepaid expenses and other receivables	1,019	1,988
Total current assets	16,526	10,971
LONG-TERM ASSETS:
Intangible assets, net	10,544	13,189
Goodwill	21,325	23,206
Severance pay fund	594	819
Lease deposits	70	74
Deferred tax assets	13
Property and equipment, net	2,401	2,674
Total long-term assets	34,947	39,962
Total assets	51,473	50,933
CURRENT LIABILITIES:
Trade payables	646	859
Credit line	4,900	3,245
Employees and payroll accruals	2,359	3,102
Accrued expenses and other liabilities	1,394	1,366
Earn-out consideration	2,269	1,428
Deferred revenues	4,097	4,499
Deferred tax liability	120
Total current liabilities	15,785	14,499
LONG-TERM LIABILITIES:
Deferred revenues	1,042	1,646
Earn-out consideration	837	2,857
Deferred tax liability	1,984	2,749
Accrued severance pay	666	873
Other liabilities	100
Total long-term liabilities	4,629	8,125
SHAREHOLDERS' EQUITY:
Ordinary shares nominal value NIS 0.15 par value- Authorized: 55,353,340 shares as of December 31, 2013 and 2014; Issued: 27,915,492 and 32,687,288 shares as of December 31, 2013 and 2014, respectively; Outstanding: 26,472,963 and 31,396,940 shares as of December 31, 2013 and 2014, respectively	1,195	986
Additional paid-in capital	203,030	191,780
Treasury shares - 1,442,529 Ordinary Shares as of December 31, 2013 and 1,290,348 Ordinary Shares as of December 31, 2014	-4,277	-4,841
Accumulated other comprehensive income (loss)	-735	1,342
Accumulated deficit	-168,154	-160,958
Total shareholders' equity	31,059	28,309
Total liabilities and shareholders' equity	$51,473	$50,933

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
CONSOLIDATED BALANCE SHEETS [Abstract]
Ordinary shares, par value	$0.15	$0.15
Ordinary shares, shares authorized	55,353,340	55,353,340
Ordinary shares, shares issued	32,687,288	27,915,492
Ordinary shares, shares outstanding	31,396,940	26,472,963
Treasury stock, shares	1,290,348	1,442,529

CONSOLIDATED_STATEMENTS_OF_INC

CONSOLIDATED STATEMENTS OF INCOME (LOSS) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
CONSOLIDATED STATEMENTS OF INCOME (LOSS) [Abstract]
Revenues	$31,925	$32,248	$23,910
Cost of revenues	8,123	7,695	4,397
Gross profit	23,802	24,553	19,513
Operating expenses:
Research and development, net	11,222	9,270	6,528
Sales and marketing	11,802	10,278	5,566
General and administrative	8,047	10,388	6,639
Adjustment to earn-out consideration	-744	-3,276
Total operating expenses	30,327	26,660	18,733
Operating income (loss)	-6,525	-2,107	780
Loss from sale of investment in affiliate		-1,289
Other income, net	187
Financial income (expenses), net	-874	-1,255	80
Income (loss) before taxes on income	-7,212	-4,651	860
Tax benefit (expense)	196	-5,220	625
Net income (loss)	($7,016)	($9,871)	$1,485
Basic and diluted net earnings (loss) per share	($0.25)	($0.38)	$0.06
Weighted average number of shares used in computing basic net earnings per share	28,598,323	26,231,254	24,610,267
Weighted average numbers of shares used in computing diluted net earnings per share	28,598,323	26,231,254	25,140,439

CONSOLIDATED_STATEMENTS_OF_COM

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) [Abstract]
Net income (loss)	($7,016)	($9,871)	$1,485
Other comprehensive income (loss):
Foreign currency translation adjustments	-2,077	873	446
Total comprehensive income (loss)	($9,093)	($8,998)	$1,931

STATEMENTS_OF_CHANGES_IN_SHARE

STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (USD $)	Total	Ordinary Shares [Member]	Additional paid-in capital [Member]	Treasury stock [Member]	Accumulated other comprehensive income (loss) [Member]		Accumulated deficit [Member]
In Thousands, except Share data
Balance at Dec. 31, 2011	$28,824	$960	$188,463	($8,692)	$23	[1]	($151,930)
Balance, shares at Dec. 31, 2011		24,093,617
Purchase of treasury shares, value	-1,720			-1,720
Purchase of treasury shares, shares		-600,337
Issuance of shares upon exercise of options	712	26	686
Issuance of shares upon exercise of options, shares		627,583
Issuance of treasury shares upon acquisitions, value	3,510		104	3,406
Issuance of treasury shares upon acquisitions, shares		1,556,750
Issuance of treasury shares upon exercise of options	178		-104	353			-71
Issuance of treasury shares upon exercise of options, shares		148,721
Stock-based compensation related to options granted to non-employees	11		11
Stock-based compensation related to employees	1,276		1,276
Other comprehensive income (loss)	446				446	[1]
Net income (loss)	1,485						1,485
Balance at Dec. 31, 2012	34,722	986	190,436	-6,653	469	[1]	-150,516
Balance, shares at Dec. 31, 2012		25,826,334
Issuance of treasury shares upon exercise of options	1,241			1,812			-571
Issuance of treasury shares upon exercise of options, shares		646,629
Stock-based compensation related to options granted to non-employees	30		30
Stock-based compensation related to employees	1,314		1,314
Other comprehensive income (loss)	873				873	[1]
Net income (loss)	-9,871						-9,871
Balance at Dec. 31, 2013	28,309	986	191,780	-4,841	1,342	[1]	-160,958
Balance, shares at Dec. 31, 2013	26,472,963	26,472,963
Issuance of shares and warrants upon public offering ($2.41 per combination), net of $1,261 issuance expenses	10,239	209	10,030
Issuance of shares and warrants upon public offering ($2.41 per combination), net of $1,261 issuance expenses, shares		4,771,796
Issuance of treasury shares upon exercise of options	384			564			-180
Issuance of treasury shares upon exercise of options, shares		152,181
Stock-based compensation related to options granted to non-employees	38		38
Stock-based compensation related to employees	1,182		1,182
Other comprehensive income (loss)	-2,077				-2,077	[1]
Net income (loss)	-7,016						-7,016
Balance at Dec. 31, 2014	$31,059	$1,195	$203,030	($4,277)	($735)	[1]	($168,154)
Balance, shares at Dec. 31, 2014	31,396,940	31,396,940
[1]	Relates to foreign currency translation adjustments.

STATEMENTS_OF_CHANGES_IN_SHARE1

STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) (USD $)	0 Months Ended	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jul. 30, 2014	Dec. 31, 2014
STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY [Abstract]
Issuance of shares and warrants upon public offering (in dollars per share)	$2.41	$2.41
Issuance of shares and warrants upon public offering, issuance expenses	$1,261	$1,261

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities:
Net income (loss)	($7,016)	($9,871)	$1,485
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Loss on disposal of property and equipment	15	18
Depreciation	1,285	1,136	560
Stock-based compensation	1,220	1,344	1,287
Amortization of intangible assets	1,736	1,755	589
Accrued interest, accretion of discount and exchange rate differences on credit line	124	84
Accretion and change in fair value of earn-out liabilities, net	-445	-2,398	224
Loss from sale of investment in affiliate		1,289
Deferred taxes, net	-318	4,980	-806
Changes in assets and liabilities:
Trade receivables	866	868	-2,194
Prepaid expenses and other receivables	839	-511	-541
Trade payables	-542	-248	300
Employees and payroll accruals, accrued expenses and other liabilities	-496	595	-1,085
Deferred revenues	-1,047	1,180	-164
Accrued severance pay, net	18	-105	-2
Other long-term liabilities	100
Net cash provided by (used in) operating activities	-3,661	116	-347
Cash flows from investing activities:
Payment for business acquisitions, net of cash acquired			-10,243
Change in long-term lease deposits	1	-17	-17
Proceeds from sale of property and equipment	9	4
Proceeds from sale of investment in affiliate		194
Investment in affiliate		-80	-176
Purchase of property and equipment	-771	-2,053	-805
Net cash used in investing activities	-761	-1,952	-11,241
Cash flows from financing activities:
Proceeds from public offering, net	10,239
Payment of earn-out consideration	-351	-3,994	-3,400
Purchase of treasury shares			-1,720
Proceeds from bank loans and credit line	6,800	6,165
Repayment of bank loans and credit line	-5,270	-3,004
Proceeds from options exercised	384	1,241	890
Net cash provided by (used in) financing activities	11,802	408	-4,230
Effect of exchange rate changes on cash and cash equivalents	-74	48	87
Increase (decrease) in cash and cash equivalents	7,306	-1,380	-15,731
Cash and cash equivalents at the beginning of the year	3,757	5,137	20,868
Cash and cash equivalents at the end of the year	11,063	3,757	5,137
Cash paid during the year for:
Taxes	211	352	148
Interest	279	142
Non-cash transactions:
Purchase of property and equipment by credit	($324)	($145)	($48)

General

General	12 Months Ended
	Dec. 31, 2014
General [Abstract]
General	NOTE 1:	GENERAL
		a.	CYREN Ltd. (henceforth "CYREN") was incorporated as under the laws of the State of Israel on February 10, 1991 and its legal form is a company limited by shares. CYREN listed its shares to the public on July 15, 1999 under the name Commtouch Software Ltd. and changed its legal name to CYREN Ltd. in January 2014. CYREN and its subsidiaries, unless otherwise indicated will be referred to in these consolidated financial statements as the “Company”.
	The Company develops and provides Internet security solutions to Original Equipment Manufacturer ("OEM") partners and enterprises. The Company's business is to develop and sell, through a variety of third party distribution channels, these solutions to various customers. The Company's offerings include several security services in the area of email security, web security, and antimalware. The Company operates in one reportable segment.
		b.	Acquisition of Frisk Software:
	On October 1, 2012, the Company completed the acquisition of the antivirus business of Frisk Software, an Incorporated Icelandic private limited company, or "Frisk". The acquisition accelerated CYREN's antivirus roadmap and enabled the Company to more quickly provide the most advanced antivirus technology utilizing the combined resources of both organizations. It also helps support the launch of private label antivirus solution for the OEM and service provider markets while also enhancing the Company's Software-as-a-Service (“SaaS”) capabilities.
	The purchase price amounted to $4,915 thousand, out of which $2,200 thousand was paid in cash and $1,678 thousand was paid by issuance of 750,000 Ordinary Shares at the closing date. The remainder of the purchase price was comprised of an earn-out consideration which is based on revenues for each of the years ended December 31, 2013 and December 31, 2014 and revenue in respect of the first quarter of 2015. A payment of $51 thousand and $351 thousand was made in 2013 and 2014 respectively, on account of the earn-out and an additional contingent consideration with an estimated fair value of $456 thousand as of December 31, 2014, will be paid based on future revenues. The fair value of the earn-out liability was adjusted downward during 2013 and 2014 to adjust to the new forecasted revenues. As a result, the fair value of the Frisk earn-out liability was reduced by $397 thousand and $7 thousand for the years ended December 31, 2013 and 2014, respectively.
	The total purchase price was allocated to the net tangible and identifiable intangible assets based on their fair values at the acquisition date as set forth below. The excess of the purchase price over the net tangible and identifiable intangible assets was assigned to goodwill. The value of goodwill is attributed to operational synergies between CYREN and Frisk and to the strengthening of the Company's position in the market.
	The following table summarizes the fair values of the assets acquired and liabilities assumed (in thousands):
	Cash and cash equivalents		$	202
	Trade receivables			36
	Prepaid expenses and other receivables			287
	Property and equipment			64
	Intangible assets			2,250
	Goodwill			3,501
	Total assets acquired			6,340
	Trade payables			(571	)
	Deferred revenues			(565	)
	Long-term deferred tax liabilities			(289	)
	Total liabilities assumed			(1,425	)
	Net assets acquired		$	4,915
	Intangible assets that are subject to amortization are amortized over their estimated useful lives using the straight-line method at an annual weighted average rate of 8%. The following table sets forth the components of intangible assets associated with the acquisition and their annual rates of amortization (in thousands):
			Fair value			%
	Trademark		$	984			10
	Intellectual property			1,266			6.7
	Total intangible assets		$	2,250
		c.	Acquisition of eleven GmbH:
	On November 16, 2012, the Company completed the acquisition of eleven GmbH, a Germany based company, or "eleven". eleven is well known throughout Germany as the leading provider of mail-based Security-as-a-Service (“SecaaS”) solutions.
	The purchase price amounted to $22,293 thousand out of which, $11,543 thousand was paid in cash and $1,832 thousand was paid by issuance of 806,750 Ordinary Shares at the closing date. The remainder of the purchase price was comprised by an earn-out consideration which is based on revenues for each of the years ended December 31, 2013, 2014 and 2015. A payment of $3,943 thousand and zero was made in 2013 and 2014 on account of the earn-out and an additional contingent consideration with an estimated fair value of $2,650 thousand, based on future revenues, as of December 31, 2014, may be due for payment. The fair value of the earn-out liability was adjusted downward during 2013 and 2014 to adjust to the new forecasted revenues. As a result, the fair value of the eleven earn-out liability was reduced by $2,879 thousand and $737 thousand for the years ended December 31, 2013 and 2014, respectively. See also note 7(c)(2) regarding ongoing litigation with the former eleven shareholders with respect to the earn-out liability.
	The total purchase price was allocated to the Company's business net tangible and identifiable assets based on their fair values at the acquisition date as set forth below. The excess of the purchase price over the net tangible and identifiable intangible assets was assigned to goodwill. The value of goodwill is attributed to synergies between CYREN and eleven's services and to the strengthening of the Company's position in the market.
	The following table summarizes the fair values of the assets acquired and liabilities assumed (in thousands):
	Cash and cash equivalents		$	3,297
	Trade receivables			846
	Prepaid expenses and other receivables			252
	Property and equipment			449
	Other intangible assets			9,100
	Goodwill			14,732
	Total assets acquired			28,676
	Trade payables			(128	)
	Employees and payroll accruals			(194	)
	Accrued expenses and other liabilities			(2,313	)
	Deferred revenues			(844	)
	Long-term deferred tax liabilities			(2,904	)
	Total liabilities assumed			(6,383	)
	Net assets acquired		$	22,293
	The intangible assets that are subject to amortization are amortized over their estimated useful lives using the straight-line method at an annual weighted average rate of 10.0%, except for customer relations which is amortized on an accelerated basis.
	The following table sets forth the components of intangible assets associated with the acquisition and their annual rates of amortization:
	(in thousands)		Fair value			%
	Trademark		$	671			10
	Customer relations			3,037			Accelerated method
	Technology			4,611			10
	In-process R&D (*)			781			(*)
	Total intangible assets		$	9,100
		(*)	The in-process research and development ("IPR&D") is amortized when the development is completed. Commencing January 2013, the Company began amortizing a portion of the IPR&D, in the amount of $169 thousand and with an estimated useful life of ten years, related to the development of a specific product which had become available for general release. Commencing January 2014, the Company began amortizing the remainder of the IPR&D, in the amount of $612 thousand and with an estimated useful life of 9 years, related to the development of another specific product which had become available for general release.

Significant_Accounting_Policie

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2014
Significant Accounting Policies [Abstract]
Significant Accounting Policies	NOTE 2:          SIGNIFICANT ACCOUNTING POLICIES
	The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP").
		a.	Use of estimates:
	The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company's management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. On an ongoing basis, the Company's management evaluates estimates, including those related to fair value and useful lives of intangible assets, fair value of earn-out liabilities, valuation allowance on deferred tax assets, income tax uncertainties, fair values of stock-based awards, other contingent liabilities and estimates used in applying the revenue recognition policy. Such estimates are based on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.
		b.	Financial statements in U.S. dollars:
	CYREN's revenues, and certain of its subsidiary's revenues, are generated mainly in U.S. dollars. In addition, most of their costs are incurred in U.S. dollars. The Company's management believes that the U.S. dollar is the primary currency of the economic environment in which CYREN and certain of its subsidiaries operate. Thus, the functional and reporting currency of CYREN and certain of its subsidiaries is the U.S. dollar.
	CYREN and certain subsidiaries' transactions and balances denominated in dollars are presented at their original amounts. Non-dollar transactions and balances have been re-measured to dollars in accordance with ASC 830, "Foreign Currency Matters". All transaction gains and losses from re-measurement of monetary balance sheet items denominated in non-dollar currencies are reflected in the statements of income (loss) as financial income or expenses, as appropriate.
	For those subsidiaries whose functional currency has been determined to be their local currency, assets and liabilities are translated at year-end exchange rates and statement of income (loss) items are translated at average exchange rates prevailing during the year. Such translation adjustments are recorded as a separate component of accumulated other comprehensive income (loss) in shareholders' equity.
		c.	Principles of consolidation:
	The consolidated financial statements include the accounts of CYREN and its subsidiaries. All intercompany balances and transactions have been eliminated upon consolidation.
		d.	Cash equivalents:
	Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less at acquisition.
		e.	Restricted cash:
	The Company maintains certain cash amounts restricted as to withdrawal or use. On December 31, 2014, the Company maintained a balance of $118 thousand that represents security deposits with respect to leases, restricted due to the lease agreement and security deposits for credit lines from banks. Restricted cash is presented within the prepaid expenses and other receivables balance.
		f.	Investment in affiliates:
	The Company's investments in affiliated companies comprises of investments in which the Company owns less than 20.0% or in which the Company cannot exercise significant influence over the affiliates' operating and financial policies. These investments are stated at cost.
	The Company's investments are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an investment may not be recoverable. In 2013, the Company sold an investment in affiliate for a consideration of $194 thousand and recognized a loss of $1,289 thousand for the year ended December 31, 2013. The investment in affiliate balance has been zero since December 31, 2013 and no new investments were made during the year-ended December 31, 2014.
		g.	Property and equipment:
	Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at the following annual rates:
			%
	Computers and peripheral equipment		33.33
	Office furniture and equipment		7.0 – 20.0
	Motor vehicles		15
	Leasehold improvements		Over the shorter of the term of the lease or the life of the assets
		h.	Intangible assets:
	Intangible assets that are not considered to have an indefinite useful life are amortized over their estimated useful lives, which range from 7 to 14 years. Acquired customer contracts and relationships are amortized over their estimated useful lives in proportion to the economic benefits realized. This accounting policy results in accelerated amortization of such customer contracts and relationships arrangements as compared to the straight-line method. Technology, Intellectual Property and Trademark are amortized over their estimated useful lives on a straight-line basis.
	Acquired in-process research and development is not amortized during the development period after the acquisition, instead, it is subject to the impairment review for indefinite-lived intangibles. Upon completion of the development process for the acquired research and development ("R&D"), the Company determines the useful life of the asset resulting from R&D activities and begins amortizing over the estimated useful life. However, prior to changing its life from indefinite to finite, the asset is tested for impairment as if it was still indefinite-lived.
		i.	Impairment of long-lived assets:
	The Company's long-lived assets and identifiable intangibles are reviewed for impairment in accordance with ASC 360 "Property, Plant and Equipment", whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.
	Recoverability of these assets is measured by comparison of the carrying amount of each asset group to the future undiscounted cash flows the asset group is expected to generate. If the asset is considered to be impaired, the amount of any impairment is measured as the difference between the carrying value and the fair value of the impaired asset.
	The Company operates as one asset group. During the year ended December 31, 2014, the Company identified the decrease in the fair value of the earn-out consideration as an indicator that the carrying value of the asset group may not be recoverable. The Company performed a recoverability test as of September 30 and December 31, 2014 and the test in both cases resulted in no impairment.
	During 2012 through 2014, no impairment losses had been identified.
		j.	Goodwill:
	Goodwill represents the excess of the purchase price in a business combination over the fair value of net tangible and intangible assets acquired. Goodwill is not amortized, but rather is subject to an impairment test.
	The Company performs an annual impairment test at December 31, of each fiscal year, or more frequently if impairment indicators are present. The Company operates in one operating segment, and this segment comprises its only reporting unit.
	ASC 350 prescribes a two-phase process for impairment testing of goodwill. The first phase screens for impairment, while the second phase (if necessary) measures impairment. Goodwill impairment is deemed to exist if the net book value of a reporting unit exceeds its estimated fair value determined using market capitalization. In such case, the second phase is then performed, and the Company measures impairment by comparing the carrying amount of the reporting unit's goodwill to the implied fair value of that goodwill. An impairment loss is recognized in an amount equal to the excess. ASC 350 allows an entity to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. An entity is not required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount.
	Alternatively, ASC 350 permits an entity to bypass the qualitative assessment for any reporting unit and proceed directly to performing the first step of the goodwill impairment test. Accordingly, the Company elected to proceed directly to the first step of the goodwill impairment test.
	For each of the three years in the period ended December 31, 2014, no impairment losses have been identified.
		k.	Fair value measurements:
	The carrying amounts of cash and cash equivalents, trade receivables, prepaid expenses, other receivables and trade payables, approximate their fair values due to the short-term maturities of such financial instruments.
	The Company measures its earn-out consideration at fair value. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. A three-tiered fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:
	Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company can access at the measurement date.
	Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.
	Level 3 - Unobservable inputs for the asset or liability.
	The availability of observable inputs can vary from instrument to instrument and is affected by a wide variety of factors, including, for example, the type of instrument, the liquidity of markets and other characteristics particular to the transaction. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment and the instruments are categorized as Level 3.
	The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.
	The Company's earn-out considerations are classified within Level 3. The valuation methodology used by the Company to calculate the fair value of the earn-out considerations is the discounted cash-flow method. The assumptions used in the valuation of the earn-out considerations as of December 31, 2014 included forecasted future revenues and a weighted average cost of capital of 14.32% - 16.63%.
		l.	Revenue recognition:
	The Company derives its revenues from the delivery of real-time cloud-based services for each of the email security, web security, and antimalware offerings.
	Revenue is recognized when there is persuasive evidence of an arrangement, the service has been rendered, the collection of the fee is probable and the amount of fees to be paid by the customer is fixed or determinable.
	Revenues from such services are recognized ratably over the contractual service term, which generally includes a term period of one to three years.
	Deferred revenues include unearned amounts received from customers, but not yet recognized as revenues.
		m.	Research and development costs:
	Research and development costs are charged to statements of income (loss) as incurred.
		n.	Government grants:
	The Company receives government grants for funding certain approved research and development projects.  These grants are recognized at the time the Company is entitled to such grants, on the basis of the related costs incurred and recorded as a deduction of research and development costs. Research and development grants amounted to $257 thousand, $505 thousand and $516 thousand in 2012, 2013 and 2014, respectively.
		o.	Concentrations of credit risk:
	The Company has no significant off-balance-sheet concentration of credit risk.
	Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and trade receivables. The majority of the Company's cash and cash equivalents are invested in dollars and are deposited in major banks in the United States, Germany, Iceland and Israel. Such investments in the United States may be in excess of insured limits and are not insured in other jurisdictions. Management believes that the financial institutions that hold the Company's investments are institutions with high credit standing, and accordingly, minimal credit risk exists with respect to these investments.
	The trade receivables of the Company are derived from transactions with companies located primarily in North America, Europe, Israel and Asia. An allowance for doubtful accounts is determined with respect to those amounts that the Company has determined to be doubtful of collection. The provision for doubtful accounts amounted $1,070 thousand and $759 thousands at December 31, 2013 and 2014 respectively. Bad debt expense (benefit) for each of the years ended December 31, 2012, 2013 and 2014 was $456 thousand, $672 thousand and ($73) thousand, respectively.
		p.	Accounting for stock-based compensation:
	ASC 718 - "Compensation-stock Compensation"- ("ASC 718") requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company's consolidated statements of income (loss).
	The Company recognizes compensation expense for the value of its awards on a straight-line basis over the requisite service period of each of the awards, net of estimated forfeitures. Estimated forfeitures are based on actual historical pre-vesting forfeitures. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.
	The Company estimates the fair value of stock options granted using the Black-Scholes option-pricing model. The option-pricing model requires a number of assumptions, of which the most significant are the expected stock price volatility and the expected option term. Expected volatility was calculated based upon actual historical stock price movements. The expected term of options granted represents the period of time that options granted are expected to be outstanding, based upon historical experience. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The Company has historically not paid dividends and has no foreseeable plans to pay dividends.
The Company applies ASC 718, and ASC 505-50, "Equity Based Payments to Non-Employees" ("ASC 505-50"), with respect to options issued to non-employees.
The fair value for options granted in 2012, 2013 and 2014 is estimated at the date of grant using a Black-Scholes options pricing model with the following assumptions:
		Year ended
		December 31,
Stock options		2012	2013	2014
Volatility		38%-51%	37%-47%	38%-42%
Risk-free interest rate		0.5%-0.9%	0.5%-1.5%	1.0%-1.7%
Dividend yield		0%	0%	0%
Expected term (years)		3.8-4.9	3.5-4.9	3.3-4.9
	q.	Basic and diluted net earnings (loss) per share:
Basic net earnings (loss) per share have been computed using the weighted-average number of Ordinary Shares outstanding during the year. Diluted net earnings (loss) per share is computed based on the weighted average number of Ordinary Shares outstanding during each year, plus the weighted average number of dilutive potential Ordinary Shares considered outstanding during the year.
In  2012, the difference between the denominator of basic and diluted net earnings per share is due to the effect of dilutive securities for stock options. In 2013 and 2014 there is no difference between the denominator of basic and diluted loss per share.
The total weighted average number of shares related to the outstanding options and warrants excluded from the calculations of diluted earnings per share, since it would have an anti-dilutive effect, was 3,156,346, 4,864,218 and 5,837,758 for 2012, 2013 and 2014, respectively.
	r.	Severance pay:
The Company's liability for severance pay in Israel is calculated pursuant to Israel's Severance Pay Law based on the most recent salary of the employees multiplied by the number of years of employment as of the balance sheet date. Employees are entitled to one month's salary for each year of employment or a portion thereof. The Company's obligation for all of its Israeli employees is fully provided by monthly deposits with severance pay funds and insurance policies, and by an accrual. The value of those funds and policies is recorded as an asset in the Company's balance sheet.
The deposited funds include profits and losses accumulated up to the balance sheet date. The deposited funds may be withdrawn only upon the fulfillment of the obligation pursuant to Israel's Severance Pay Law or labor agreements. The value of the deposited funds is based on the cash surrendered value of these policies.
Effective October, 2014, the Company's agreements with employees in Israel, are under Section 14 of the Severance Pay Law, 1963. The Company's contributions for severance pay have replaced its severance obligation. Upon contribution of the full amount of the employee's monthly salary for each year of service, no additional calculations is conducted between the parties regarding the matter of severance pay and no additional payments is made by the Company to the employee. Further, the related obligation and amounts deposited on behalf of the employee for such obligation are not stated on the balance sheet, as the Company is legally released from the obligation to employees once the deposit amounts have been paid.
Severance expense (benefit) for the years ended December 31, 2012, 2013 and 2014 was ($2) thousand, $105 thousand and $26 thousand, respectively.
	s.	Treasury shares:
The Company repurchases its Ordinary Shares from time to time on the open market and holds such shares as treasury shares. The Company presents the cost to repurchase treasury shares as a reduction in shareholders' equity.
The Company reissues treasury shares under the stock purchase plan, upon exercise of option and upon issuance of shares upon acquisitions. Reissuance of treasury shares is accounted for in accordance with ASC 505-30 whereby gains are credited to additional paid-in capital and losses are charged to additional paid-in capital to the extent that previous net gains are included therein; otherwise to accumulated deficit.
	t.	Income taxes:
The Company accounts for income taxes in accordance with ASC 740, "Income Taxes" ("ASC 740"). ASC 740  prescribes the use of the liability method whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance to reduce deferred tax assets to amounts more likely than not to be realized.
Deferred tax assets are classified as current or non-current based on the classification of the related asset or liability for financial reporting, or according to the expected reversal dates of the specific temporary differences if not related to an asset or liability for financial reporting.
ASC 740 contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50.0% likely to be realized upon ultimate settlement.
	u.	Comprehensive income:
The Company accounts for comprehensive income in accordance with ASC No. 220, "Comprehensive Income". Comprehensive income generally represents all changes in shareholders' equity during the period except those resulting from investments by, or distributions to, shareholders. The Company determined that its items of other comprehensive income (loss) relate to gains and losses from functional currency translation adjustments on behalf of subsidiaries whose functional currency has been determined to be their local currency.
	v.	Reclassifications:
Certain reclassifications of previously reported amounts have been made to conform to the current year presentation. Certain overhead expenses and salaries that were previously reported as sales and marketing (“S&M') in the amount of $294 thousand and $608 thousand have been reclassified to cost of revenues in the consolidated statements of income (loss) for the year ended December 31, 2012 and 2013, respectively. Certain outside services expenses that were previously reported as cost of revenues in the amount of $247 thousand and $114 thousand have been reclassified to R&D in the consolidated statements of income (loss) for the year ended December 31, 2012 and 2013, respectively. The Company reviewed the impact of these reclassifications and determined that the reclassifications were not material on the prior year's consolidated financial statements.
	w.	Recently issued accounting standards:
In May 2014, the Financial Accounting Standards Board, or FASB, issued an Accounting Standard Update, or ASU, on revenue from contracts with customers, which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance. This ASU, which will be effective for the Company beginning January 1, 2017, allows for either full or modified retrospective methods of adoption and early adoption is not permitted. The Company is currently evaluating the method of adoption, as well as the effect that adoption of this ASU will have on its consolidated financial statements.
In 2014, the FASB issued ASU 15-2014, Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern, which defines management's responsibility to assess an entity's ability to continue as a going concern, and to provide related footnote disclosures if there is substantial doubt about its ability to continue as a going concern. The pronouncement is effective for annual reporting periods ending after December 15, 2016 with early adoption permitted. The Company is currently evaluating the effect, if any, that the adoption of this guidance will have on its consolidated financial statements.

Property_And_Equipment_Net

Property And Equipment, Net	12 Months Ended
	Dec. 31, 2014
Property And Equipment, Net [Abstract]
Property And Equipment, Net	NOTE 3:          PROPERTY AND EQUIPMENT, NET
		31-Dec
	(in thousands)	2013			2014
	Cost:
	Computers and peripheral equipment	$	7,350		$	8,160
	Office furniture and equipment		1,112			1,151
	Motor vehicles		10			-
	Leasehold improvements		1,581			1,587
			10,053			10,898
	Less accumulated depreciation		(7,379	)		(8,497	)
	Property and equipment, net	$	2,674		$	2,401
	Depreciation expense amounted to $560 thousand, $1,136 thousand and $1,285 thousand in 2012, 2013 and 2014, respectively.

Intangible_Assets_Net

Intangible Assets, Net	12 Months Ended
	Dec. 31, 2014
Intangible Assets, Net [Abstract]
Intangible Assets, Net	NOTE 4:	INTANGIBLE ASSETS, NET
	a.           Definite-lived intangible assets:
			December 31,
	(in thousands)		2013			2014
	Original amounts:
	Customer contracts and relationships		$	5,754		$	5,367
	Technology			7,961			8,092
	Trademarks			1,709			1,623
	In-process R&D			674			-
				16,098			15,082
	Accumulated amortization:
	Customer contracts and relationships			(1,378	)		(1,980	)
	Technology			(1,326	)		(2,201	)
	Trademarks			(205	)		(357	)
	Accumulated amortization			(2,909	)		(4,538	)
	Intangible assets, net		$	13,189		$	10,544
	b.          Amortization expense amounted to $589 thousand, $1,755 thousand and $1,736 thousand for 2012, 2013 and 2014, respectively.

Goodwill

Goodwill	12 Months Ended
	Dec. 31, 2014
Goodwill [Abstract]
Goodwill	NOTE 5:	GOODWILL
	The changes in the carrying amount of goodwill for the year ended December 31, 2013 and 2014 are as follows:
			Year ended
			December 31,
	(in thousands)		2013		2014
	Balance at the beginning of the year		$	22,518	$	23,206
	Foreign currency translation adjustments			688		(1,881	)
	Balance at the year end		$	23,206	$	21,325

Credit_Line

Credit Line	12 Months Ended
	Dec. 31, 2014
Credit Line [Abstract]
Credit Line	NOTE 6:	CREDIT LINE
	On October 21, 2013, the Company entered into a credit line agreement with a U.S. bank, under which the bank provides the Company with a credit line of $7.5 million for a period of one year. In April 2014 the agreement was extended up to April 20, 2015. The amounts drawn down from the credit line are subject to interest equal to the Prime Rate in effect from time to time, plus 2.75% per annum, provided that the interest rate in effect on any day shall not be less than 6.0% per annum. In relation to this credit line, the Company is obliged by the bank to comply with certain financial covenants, as defined in the agreement and has agreed to grant security interests generally over all Company assets, and to refrain from encumbering its assets in favor of any other third parties. As of December 31, 2014, the Company had drawn down an amount of $4.8 million from the credit line and was in full compliance with the financial covenants.
	On March 20, 2015 the Company signed an amendment to the credit line agreement with the U.S. bank modifying the maturity date to March 20, 2016. The credit line limit decreased to $6.0 million at the Company's request and the interest rate decreased to the Prime Rate in effect from time to time, plus 2.75% per annum, provided that the interest rate in effect on any day shall not be less than 5.5% per annum, provided, however, that the Company pay a minimum aggregate amount of interest of no less than $18 thousand per month. In addition, the financial covenants the Company is obliged to comply with were also amended to meet the Company's expected business requirements for the year.

Commitments_And_Contingencies

Commitments And Contingencies	12 Months Ended
	Dec. 31, 2014
Commitments And Contingencies [Abstract]
Commitments And Contingencies	NOTE 7:	COMMITMENTS AND CONTINGENCIES
		a.	CYREN Ltd., which was incorporated in Israel, partially financed its research and development expenditures under programs sponsored by the Office of Chief Scientist ("OCS") for the support of certain research and development activities conducted in Israel.
	In connection with specific research and development, the Company received $1,184 thousand of participation payments from the OCS. In return for the OCS's participation in this program, the Company is committed to pay royalties at a rate of 3.0% of the developed product sales for the program through 2012 and 3.5% in 2013 and 2014, up to 100% of the amount of grants received plus interest at annual LIBOR rate. The Company's total commitment for royalties payable with respect to future sales, based on OCS participations received or accrued, net of royalties paid or accrued, totaled $897 thousand  as of December 31, 2014. For the years ended December 31, 2012, 2013 and 2014, $58 thousand, $78, thousand and $129 thousand, respectively, were recorded as cost of revenues with respect to royalties due to the OCS.
		b.	Operating leases:
	Certain facilities of the Company are rented under operating lease agreements, which expire on various dates, the latest of which is in 2018.
	Facilities rent expenses for 2012, 2013 and 2014 were $531 thousand $985 thousand and $1,056 thousand, respectively.
	Annual minimum future lease payments due under the above agreements (and motor vehicle leases, which expire in 2016 and other facility related leases), at the exchange rate in effect on December 31, 2014, are as follows (in thousands):
	2015		$	1,135
	2016			998
	2017			855
	2018			267
			$	3,255
		c.	Litigations:
	(1)       The Company's German subsidiary is currently involved in one lawsuit that was initiated prior to the acquisition of eleven GmbH: a claim by a former employee regarding payment of a commission. This case was settled during 2014 and the Company recorded a provision of €275 thousand under accrued expenses and other liabilities as of December 31, 2014.
	(2)        In 2014, the Company entered into arbitral proceedings with the former shareholders of eleven regarding an escrow agreement. CYREN and the former eleven shareholders are disputing an amount of €740 thousand in the escrow account. In addition to the escrow dispute, CYREN has initiated claims for €1,466 thousand against the former eleven shareholders relating to the earn-out liability of the eleven acquisition while the former shareholders claim payment of €781 thousand from CYREN with regards to the same liability. See also note 1(c) for further details on the earn-out liability. Considering the preliminary stage of these arbitral proceedings, the Company has determined it is currently unable to predict the outcome of these disputes. The Company intends to defend vigorously against the claims raised by the former eleven shareholders.

Shareholders_Equity

Shareholders' Equity	12 Months Ended
	Dec. 31, 2014
Shareholders' Equity [Abstract]
Shareholders' Equity	NOTE 8:	SHAREHOLDERS' EQUITY
		a.	General:
	Ordinary shares confer upon their holders the right to receive notice to participate and vote in general shareholder meetings of the Company and to receive dividends, if declared.
		b.	Public offering:
	On July 30, 2014, the Company completed a public offering of 4,771,796 Ordinary Shares, nominal value NIS 0.15 per share, and warrants (the “Warrants”) to purchase an aggregate of 1,670,128 Ordinary Shares in combinations consisting of one Ordinary Share and one warrant to purchase 0.35 of an Ordinary Share, at an offering price per fixed combination of $2.41. Each Warrant has an exercise price of $3.08 per share, will be exercisable following the six-month anniversary of the date of its issuance and will expire ninety months following the date of its issuance. The Company received total proceeds of $10,239 thousand which is net of $1,261 thousand issuance expenses.
		c.	Employee and directors stock options:
	In 1996, the Company adopted the 1996 CSI Stock Option Plan for granting options to its U.S. employees and consultants to purchase Ordinary Shares of the Company, which was replaced in 2006 by the 2006 U.S. Stock Option Plan. Until 1999, the Company issued options to purchase Ordinary Shares to its Israeli employees pursuant to individual agreements. In 1999, the Company approved the 1999 Section 3(i) share option plan for its Israeli employees and consultants, (which was amended in 2003 and renamed the "Amended and Restated Israeli Share Option Plan"). As of December 31, 2014 an aggregate of 2,088,463 Ordinary Shares of the Company, are still available for future grant to employees and directors.
	Options granted under such plans and agreements through September 2005, generally expire after ten years from the date of grant and options granted after September 2005 generally expire six years from the date of grant. Options cease vesting upon termination of the optionee's employment or other relationship with the Company. The options generally vest over a period of four to six years. The per share exercise price shall be no less than 100% of the fair market value per Ordinary Share on the date of grant. Any options that are canceled or not exercised within the option term become available for future grant.
		d.	Directors stock option plan:
	In 1999, the Company adopted the 1999 Directors Stock Option Plan, and in 2008 shareholders approved an extension of the term of this plan through July 13, 2019. The original allotment of Ordinary Shares to this plan was 1,263,333. On December 15, 2006, the Company combined the remaining pool of options in the employee stock option plans reserve with the amount of options remaining in the Directors Stock Option Plan reserve.
	Each option granted under the Directors Stock Option Plan becomes exercisable at a rate of 1/16th of the shares every three months. Each option has an exercise price equal to the fair market value of the Ordinary Shares on the grant date of such option. Until September 2005, each option granted had a maximum term of ten years, and since September 2005, the term of granted options is six years. Options will terminate earlier if the optionee ceases to be a member of the Board of Directors.
		e.	A summary of the Company's employees and directors share option activity under the plans is as follows (in thousands, except share and per share data):
			Number of options			Weighted average			Weighted average			Aggregate intrinsic
									remaining			value
						exercise price			contractual term
									(years)
			2013
	Outstanding at January 1, 2014			5,266,487		$	3.02			4.49		$	1,073
	Granted			1,170,002			2.67
	Exercised			-152,181			2.52
	Expired and forfeited			-1,580,629			3.13
	Outstanding at December 31, 2014			4,703,679			2.91			5.16			55
	Options vested and expected to vest at December 31, 2014			4,388,419			2.92			5.11			50
	Exercisable options at December 31, 2014			1,976,892			3.11			4.17			-
	Weighted average fair value of options granted during the year						0.84
	As of December 31, 2014, the Company had $2,116 thousand of unrecognized compensation expense related to non-vested stock options, expected to be recognized over a remaining weighted average period of 2.72 years.
		f.	The employee and director options outstanding as of December 31, 2014, have been separated into ranges of exercise prices, as follows:
	Outstanding												Exercisable
	Exercise						Weighted average			Weighted average						Weighted average
							remaining			exercise						exercise
	price per			Options			contractual			price per			Options			price per
	share			outstanding			life in years			share			exercisable			share
	$1.56-$2.34				496,669			5.61		$	1.73			26,667	$	2
	$2.44-$2.93				1,702,837			4.39		$	2.68			691,811	$	2.65
	$3.01-$3.14				726,390			4.43		$	3.1			272,699	$	3.11
	$3.16-$3.32				967,116			4.43		$	3.28			252,509	$	3.21
	$3.41-$3.69				661,834			2.39		$	3.47			584,373	$	3.47
	$3.75-$3.94				148,833			1.54		$	3.89			148,833	$	3.89
					4,703,679			4.16		$	2.92			1,976,892	$	3.11
		g.	Options to non-employees:
	Issuance date		Options			Exercise price			Options			Exercisable through
			outstanding			per share			exercisable
	16-Feb-12			53,000		$	3.16			36,493		16-Feb
	13-Feb-13			5,000		$	3.14			2,296		19-Feb
	1-Aug-13			150,000		$	3.08			50,000		19-Aug
	14-May-14			3,000		$	3.32			-		20-May
				211,000						88,789
	The options vest and become exercisable at a rate of 1/16 of the options every three months.
	As of December 31, 2014, the Company had approximately $32 thousand of unrecognized compensation expense related to non-employee, non-vested stock options, expected to be recognized over a weighted average period of 2.43 years.
		h.	Total stock-based compensation expenses recognized in 2012, 2013 and 2014:
	The total stock-based compensation expense related to all of the Company's equity-based awards, recognized for the years ended December 31, 2012, 2013 and 2014, was as follows:
			Year ended
			December 31,
	(in thousands)		2012			2013			2014
	Cost of revenues		$	53		$	50		$	55
	Research and development			231			267			292
	Sales and marketing			200			264			292
	General and administrative			803			763			581
			$	1,287		$	1,344		$	1,220

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2014
Income Taxes [Abstract]
Income Taxes	NOTE 9:	INCOME TAXES
		a.	Corporate tax structure:
	The Israeli corporate tax rate was 25.0% in 2012 and 2013, and 26.5% in 2014.
	Non-Israeli subsidiaries are taxed according to the tax laws in their respective countries of residence.
	The Company does not provide deferred tax liabilities when it intends to reinvest earnings of foreign subsidiaries indefinitely. Undistributed earnings of foreign subsidiaries that are considered to be permanently reinvested amounted to $1,775 thousand and unrecognized deferred tax liability related to such earnings amounted to $532 thousand as of December 31, 2014.
		b.	Tax benefits under Israel's Law for the Encouragement of Industry (Taxation), 1969:
	The Company may currently qualify as an "industrial company" within the definition of the Law for the Encouragement of Industry (Taxation), as such, it may be eligible for certain tax benefits, including, inter alia, special depreciation rates for machinery, equipment and buildings, amortization of patents, certain other intangible property rights and deduction of share issuance expenses.
		c.	Net operating loss carry-forwards:
	As of December 31, 2014, CYREN's net operating loss carryforwards for tax purposes amounted to $54,794 thousand and capital loss carryforwards of $15,658 thousand which may be carried forward and offset against taxable income in the future, for an indefinite period.
	As of December 31, 2014, for federal income tax purposes, the U.S. subsidiary had net operating loss carryforward of $96,424 thousand. These losses may offset any future U.S. taxable income of the U.S. subsidiary and will expire in the years 2018 through 2034.
	Utilization of U.S. net operating losses may be subject to substantial annual limitation due to the "change in ownership" provisions of the Internal Revenue Code of 1986 and similar state provisions. The annual limitations may result in the expiration of net operating losses before utilization.
	Management currently believes that based upon its estimations for future taxable income, it is more likely than not that the deferred tax assets regarding the loss carryforwards will not be utilized in the foreseeable future. Thus, a valuation allowance was provided to reduce deferred tax assets to their realizable value.
		d.	Deferred income taxes:
	Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. As of December 31, 2013 and 2014, the Company's deferred taxes were in respect of the following:
			December 31,
	(in thousands)		2013					2014
	Deferred tax assets:
	Net operating loss carryforwards		$	48,095				$	47,524
	Capital loss carryforwards			4,842					4,149
	Temporary differences			2,734					2,630
	Deferred tax assets before valuation allowance			55,671					54,303
	Valuation allowance			(55,456		)			(54,128	)
	Deferred tax asset net of valuation allowance			215					175
	Deferred tax liabilities:
	Acquired intangibles			(2,723		)			(2,099	)
	Deferred revenue			(193		)			(167	)
	Deferred tax liability			(2,916		)			(2,266	)
	Deferred tax liability, net		$	(2,701		)		$	(2,091	)
			December 31,
	(in thousands)		2013					2014
	Foreign:
	Current deferred tax asset (liability), net		$	48				$	(120	)
	Non-current deferred tax liability, net			(2,749		)			(1,971	)
			$	(2,701		)		$	(2,091	)
			$	(2,701		)		$	(2,091	)
		e.	Reconciliation of the theoretical tax benefit (expense):
	For the year ended December 31, 2012, the main reconciling items between the Company's statutory tax rate and the effective tax rate relates to changes in valuation allowance due to utilization of net operating loss carryforwards, in the amount of $215 thousand and a decrease in valuation allowance related to net operating losses expected to be realized in the foreseeable future, in the amount of $840 thousand.
	For the year ended December 31, 2013, the main reconciling items between the Company's statutory tax rate and the effective tax rate relates to the increase in the valuation allowance in the amount of $6,431 thousand due to the management's estimations that the Company will not utilize its carryforward losses in the foreseeable future.
	For the year ended December 31, 2014, the main reconciling items between the Company's statutory tax rate and the effective tax rate relates to the decrease in valuation allowance due to the expiration of capital loss carryforwards in the amount of $1,700 thousand.
		f.	Income (loss) before tax benefit (expense) consists of the following:
			Year ended
			December 31,
			2012				2013				2014
	Domestic		$	1,430			$	(3,683	)		$	(5,342	)
	Foreign			(570	)			(968	)			(1,870	)
			$	860			$	(4,651	)		$	(7,212	)
		g.	Tax benefit (expense) is comprised of the following:
			Year ended
			December 31,
			2012				2013				2014
	Current taxes:
	Foreign		$	(124	)		$	(240	)		$	(122	)
	Domestic			(57	)			-				-
			$	(181	)		$	(240	)		$	(122	)
	Deferred taxes:
	Foreign		$	942			$	(1,065	)		$	318
	Domestic			(136	)			(3,915	)			-
			$	806			$	(4,980	)		$	318
	Tax benefit (expense), net		$	625			$	(5,220	)		$	196
		h.	A reconciliation of the beginning and ending amount of unrecognized tax benefits related to uncertain tax positions is as follows:
			December 31,
			2013					2014
	Beginning balance		$	-				$	-
	Increases related to tax positions taken during the current year			-					100
Ending balance		$	-				$	100
The entire amount of unrecognized tax benefits, if recognized, would reduce the Company's annual effective tax rate.
	i.	Tax assessments:
CYREN's tax assessments in Israel are deemed final up to and including 2010.
The U.S. subsidiary has final tax assessments up to and including 2010.
The German subsidiary has final tax assessments up to and including 2010.

Geographic_Information

Geographic Information	12 Months Ended
	Dec. 31, 2014
Geographic Information [Abstract]
Geographic Information	NOTE 10:	GEOGRAPHIC INFORMATION
	The Company manages its business on a basis of one reportable segment and follows the requirements of ASC 280 "Segment Reporting".
		a.	Revenues from external customers:
			Year ended
			December 31,
			2012		2013			2014
	United States		$	11,847	$	12,726		$	11,712
	Germany			2,147		10,321			9,191
	Europe (other than Germany)			3,590		4,086			4,635
	Asia			3,484		2,717			3,600
	Israel			2,541		1,602			1,985
	Other			301		796			802
			$	23,910	$	32,248		$	31,925
	For the years ended December 31, 2012, 2013 and 2014, the Company had no major customers.
		b.	The Company's net amount of property and equipment is as follows:
			December 31
			2013			2014
	Israel		$	830		$	661
	United States			1,090			1,177
	Germany			622			377
	Other			132			186
			$	2,674		$	2,401

Financial_Income_Expenses_Net

Financial Income (Expenses), Net	12 Months Ended
	Dec. 31, 2014
Financial Income (Expenses), Net [Abstract]
Financial Income (Expenses), Net	NOTE 11:	FINANCIAL INCOME (EXPENSE), NET
			Year ended December 31,
			2012			2013			2014
	Income:
	Interest on cash and cash equivalents and short term deposits		$	144		$	3		$	2
	Foreign currency exchange differences, net			169			-			-
				313			3			2
	Expenses:
	Accretion of earn-out consideration			(224	)		(878	)		(299	)
	Interest on bank loans and credit line			-			(197	)		(435	)
	Foreign currency exchange differences, net			-			(124	)		(48	)
	Other			(9	)		(59	)		(94	)
				(233	)		(1,258	)		(876	)
			$	80		$	(1,255	)	$	(874	)

Significant_Accounting_Policie1

Significant Accounting Policies (Policy)	12 Months Ended
	Dec. 31, 2014
Significant Accounting Policies [Abstract]
Use of Estimates		a.	Use of estimates:
	The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company's management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. On an ongoing basis, the Company's management evaluates estimates, including those related to fair value and useful lives of intangible assets, fair value of earn-out liabilities, valuation allowance on deferred tax assets, income tax uncertainties, fair values of stock-based awards, other contingent liabilities and estimates used in applying the revenue recognition policy. Such estimates are based on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.
Financial Statements In U.S. Dollars		b.	Financial statements in U.S. dollars:
	CYREN's revenues, and certain of its subsidiary's revenues, are generated mainly in U.S. dollars. In addition, most of their costs are incurred in U.S. dollars. The Company's management believes that the U.S. dollar is the primary currency of the economic environment in which CYREN and certain of its subsidiaries operate. Thus, the functional and reporting currency of CYREN and certain of its subsidiaries is the U.S. dollar.
	CYREN and certain subsidiaries' transactions and balances denominated in dollars are presented at their original amounts. Non-dollar transactions and balances have been re-measured to dollars in accordance with ASC 830, "Foreign Currency Matters". All transaction gains and losses from re-measurement of monetary balance sheet items denominated in non-dollar currencies are reflected in the statements of income (loss) as financial income or expenses, as appropriate.
	For those subsidiaries whose functional currency has been determined to be their local currency, assets and liabilities are translated at year-end exchange rates and statement of income (loss) items are translated at average exchange rates prevailing during the year. Such translation adjustments are recorded as a separate component of accumulated other comprehensive income (loss) in shareholders' equity.
Principles Of Consolidation		c.	Principles of consolidation:
	The consolidated financial statements include the accounts of CYREN and its subsidiaries. All intercompany balances and transactions have been eliminated upon consolidation.
Cash Equivalents		d.	Cash equivalents:
	Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less at acquisition.
Restricted Cash		e.	Restricted cash:
	The Company maintains certain cash amounts restricted as to withdrawal or use. On December 31, 2014, the Company maintained a balance of $118 thousand that represents security deposits with respect to leases, restricted due to the lease agreement and security deposits for credit lines from banks. Restricted cash is presented within the prepaid expenses and other receivables balance.
Investment In Affiliates		f.	Investment in affiliates:
	The Company's investments in affiliated companies comprises of investments in which the Company owns less than 20.0% or in which the Company cannot exercise significant influence over the affiliates' operating and financial policies. These investments are stated at cost.
	The Company's investments are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an investment may not be recoverable. In 2013, the Company sold an investment in affiliate for a consideration of $194 thousand and recognized a loss of $1,289 thousand for the year ended December 31, 2013. The investment in affiliate balance has been zero since December 31, 2013 and no new investments were made during the year-ended December 31, 2014.
Property And Equipment		g.	Property and equipment:
	Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at the following annual rates:
			%
	Computers and peripheral equipment		33.33
	Office furniture and equipment		7.0 – 20.0
	Motor vehicles		15
	Leasehold improvements		Over the shorter of the term of the lease or the life of the assets
Intangible Assets		h.	Intangible assets:
	Intangible assets that are not considered to have an indefinite useful life are amortized over their estimated useful lives, which range from 7 to 14 years. Acquired customer contracts and relationships are amortized over their estimated useful lives in proportion to the economic benefits realized. This accounting policy results in accelerated amortization of such customer contracts and relationships arrangements as compared to the straight-line method. Technology, Intellectual Property and Trademark are amortized over their estimated useful lives on a straight-line basis.
	Acquired in-process research and development is not amortized during the development period after the acquisition, instead, it is subject to the impairment review for indefinite-lived intangibles. Upon completion of the development process for the acquired research and development ("R&D"), the Company determines the useful life of the asset resulting from R&D activities and begins amortizing over the estimated useful life. However, prior to changing its life from indefinite to finite, the asset is tested for impairment as if it was still indefinite-lived.
Impairment of long-lived assets		i.	Impairment of long-lived assets:
	The Company's long-lived assets and identifiable intangibles are reviewed for impairment in accordance with ASC 360 "Property, Plant and Equipment", whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.
	Recoverability of these assets is measured by comparison of the carrying amount of each asset group to the future undiscounted cash flows the asset group is expected to generate. If the asset is considered to be impaired, the amount of any impairment is measured as the difference between the carrying value and the fair value of the impaired asset.
	The Company operates as one asset group. During the year ended December 31, 2014, the Company identified the decrease in the fair value of the earn-out consideration as an indicator that the carrying value of the asset group may not be recoverable. The Company performed a recoverability test as of September 30 and December 31, 2014 and the test in both cases resulted in no impairment.
	During 2012 through 2014, no impairment losses had been identified.
Goodwill		j.	Goodwill:
	Goodwill represents the excess of the purchase price in a business combination over the fair value of net tangible and intangible assets acquired. Goodwill is not amortized, but rather is subject to an impairment test.
	The Company performs an annual impairment test at December 31, of each fiscal year, or more frequently if impairment indicators are present. The Company operates in one operating segment, and this segment comprises its only reporting unit.
	ASC 350 prescribes a two-phase process for impairment testing of goodwill. The first phase screens for impairment, while the second phase (if necessary) measures impairment. Goodwill impairment is deemed to exist if the net book value of a reporting unit exceeds its estimated fair value determined using market capitalization. In such case, the second phase is then performed, and the Company measures impairment by comparing the carrying amount of the reporting unit's goodwill to the implied fair value of that goodwill. An impairment loss is recognized in an amount equal to the excess. ASC 350 allows an entity to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. An entity is not required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount.
	Alternatively, ASC 350 permits an entity to bypass the qualitative assessment for any reporting unit and proceed directly to performing the first step of the goodwill impairment test. Accordingly, the Company elected to proceed directly to the first step of the goodwill impairment test.
	For each of the three years in the period ended December 31, 2014, no impairment losses have been identified.
Fair Value Measurements		k.	Fair value measurements:
	The carrying amounts of cash and cash equivalents, trade receivables, prepaid expenses, other receivables and trade payables, approximate their fair values due to the short-term maturities of such financial instruments.
	The Company measures its earn-out consideration at fair value. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. A three-tiered fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:
	Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company can access at the measurement date.
	Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.
	Level 3 - Unobservable inputs for the asset or liability.
	The availability of observable inputs can vary from instrument to instrument and is affected by a wide variety of factors, including, for example, the type of instrument, the liquidity of markets and other characteristics particular to the transaction. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment and the instruments are categorized as Level 3.
	The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.
	The Company's earn-out considerations are classified within Level 3. The valuation methodology used by the Company to calculate the fair value of the earn-out considerations is the discounted cash-flow method. The assumptions used in the valuation of the earn-out considerations as of December 31, 2014 included forecasted future revenues and a weighted average cost of capital of 14.32% - 16.63%.
Revenue Recognition		l.	Revenue recognition:
	The Company derives its revenues from the delivery of real-time cloud-based services for each of the email security, web security, and antimalware offerings.
	Revenue is recognized when there is persuasive evidence of an arrangement, the service has been rendered, the collection of the fee is probable and the amount of fees to be paid by the customer is fixed or determinable.
	Revenues from such services are recognized ratably over the contractual service term, which generally includes a term period of one to three years.
	Deferred revenues include unearned amounts received from customers, but not yet recognized as revenues.
Research And Development Costs		m.	Research and development costs:
	Research and development costs are charged to statements of income (loss) as incurred.
Government Grants		n.	Government grants:
	The Company receives government grants for funding certain approved research and development projects.  These grants are recognized at the time the Company is entitled to such grants, on the basis of the related costs incurred and recorded as a deduction of research and development costs. Research and development grants amounted to $257 thousand, $505 thousand and $516 thousand in 2012, 2013 and 2014, respectively.
Concentrations Of Credit Risk		o.	Concentrations of credit risk:
	The Company has no significant off-balance-sheet concentration of credit risk.
	Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and trade receivables. The majority of the Company's cash and cash equivalents are invested in dollars and are deposited in major banks in the United States, Germany, Iceland and Israel. Such investments in the United States may be in excess of insured limits and are not insured in other jurisdictions. Management believes that the financial institutions that hold the Company's investments are institutions with high credit standing, and accordingly, minimal credit risk exists with respect to these investments.
	The trade receivables of the Company are derived from transactions with companies located primarily in North America, Europe, Israel and Asia. An allowance for doubtful accounts is determined with respect to those amounts that the Company has determined to be doubtful of collection. The provision for doubtful accounts amounted $1,070 thousand and $759 thousands at December 31, 2013 and 2014 respectively. Bad debt expense (benefit) for each of the years ended December 31, 2012, 2013 and 2014 was $456 thousand, $672 thousand and ($73) thousand, respectively.
Accounting For Stock-Based Compensation		p.	Accounting for stock-based compensation:
	ASC 718 - "Compensation-stock Compensation"- ("ASC 718") requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company's consolidated statements of income (loss).
	The Company recognizes compensation expense for the value of its awards on a straight-line basis over the requisite service period of each of the awards, net of estimated forfeitures. Estimated forfeitures are based on actual historical pre-vesting forfeitures. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.
	The Company estimates the fair value of stock options granted using the Black-Scholes option-pricing model. The option-pricing model requires a number of assumptions, of which the most significant are the expected stock price volatility and the expected option term. Expected volatility was calculated based upon actual historical stock price movements. The expected term of options granted represents the period of time that options granted are expected to be outstanding, based upon historical experience. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The Company has historically not paid dividends and has no foreseeable plans to pay dividends.
	The Company applies ASC 718, and ASC 505-50, "Equity Based Payments to Non-Employees" ("ASC 505-50"), with respect to options issued to non-employees.
	The fair value for options granted in 2012, 2013 and 2014 is estimated at the date of grant using a Black-Scholes options pricing model with the following assumptions:
			Year ended
			December 31,
	Stock options		2012	2013	2014
	Volatility		38%-51%	37%-47%	38%-42%
	Risk-free interest rate		0.5%-0.9%	0.5%-1.5%	1.0%-1.7%
	Dividend yield		0%	0%	0%
	Expected term (years)		3.8-4.9	3.5-4.9	3.3-4.9
Basic And Diluted Net Earnings (Loss) Per Share		q.	Basic and diluted net earnings (loss) per share:
	Basic net earnings (loss) per share have been computed using the weighted-average number of Ordinary Shares outstanding during the year. Diluted net earnings (loss) per share is computed based on the weighted average number of Ordinary Shares outstanding during each year, plus the weighted average number of dilutive potential Ordinary Shares considered outstanding during the year.
	In  2012, the difference between the denominator of basic and diluted net earnings per share is due to the effect of dilutive securities for stock options. In 2013 and 2014 there is no difference between the denominator of basic and diluted loss per share.
	The total weighted average number of shares related to the outstanding options and warrants excluded from the calculations of diluted earnings per share, since it would have an anti-dilutive effect, was 3,156,346, 4,864,218 and 5,837,758 for 2012, 2013 and 2014, respectively.
Severance Pay		r.	Severance pay:
	The Company's liability for severance pay in Israel is calculated pursuant to Israel's Severance Pay Law based on the most recent salary of the employees multiplied by the number of years of employment as of the balance sheet date. Employees are entitled to one month's salary for each year of employment or a portion thereof. The Company's obligation for all of its Israeli employees is fully provided by monthly deposits with severance pay funds and insurance policies, and by an accrual. The value of those funds and policies is recorded as an asset in the Company's balance sheet.
	The deposited funds include profits and losses accumulated up to the balance sheet date. The deposited funds may be withdrawn only upon the fulfillment of the obligation pursuant to Israel's Severance Pay Law or labor agreements. The value of the deposited funds is based on the cash surrendered value of these policies.
	Effective October, 2014, the Company's agreements with employees in Israel, are under Section 14 of the Severance Pay Law, 1963. The Company's contributions for severance pay have replaced its severance obligation. Upon contribution of the full amount of the employee's monthly salary for each year of service, no additional calculations is conducted between the parties regarding the matter of severance pay and no additional payments is made by the Company to the employee. Further, the related obligation and amounts deposited on behalf of the employee for such obligation are not stated on the balance sheet, as the Company is legally released from the obligation to employees once the deposit amounts have been paid.
	Severance expense (benefit) for the years ended December 31, 2012, 2013 and 2014 was ($2) thousand, $105 thousand and $26 thousand, respectively.
Treasury Shares		s.	Treasury shares:
	The Company repurchases its Ordinary Shares from time to time on the open market and holds such shares as treasury shares. The Company presents the cost to repurchase treasury shares as a reduction in shareholders' equity.
	The Company reissues treasury shares under the stock purchase plan, upon exercise of option and upon issuance of shares upon acquisitions. Reissuance of treasury shares is accounted for in accordance with ASC 505-30 whereby gains are credited to additional paid-in capital and losses are charged to additional paid-in capital to the extent that previous net gains are included therein; otherwise to accumulated deficit.
Income Taxes		t.	Income taxes:
	The Company accounts for income taxes in accordance with ASC 740, "Income Taxes" ("ASC 740"). ASC 740  prescribes the use of the liability method whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance to reduce deferred tax assets to amounts more likely than not to be realized.
	Deferred tax assets are classified as current or non-current based on the classification of the related asset or liability for financial reporting, or according to the expected reversal dates of the specific temporary differences if not related to an asset or liability for financial reporting.
	ASC 740 contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50.0% likely to be realized upon ultimate settlement.
Comprehensive Income		u.	Comprehensive income:
	The Company accounts for comprehensive income in accordance with ASC No. 220, "Comprehensive Income". Comprehensive income generally represents all changes in shareholders' equity during the period except those resulting from investments by, or distributions to, shareholders. The Company determined that its items of other comprehensive income (loss) relate to gains and losses from functional currency translation adjustments on behalf of subsidiaries whose functional currency has been determined to be their local currency.
Reclassifications		v.	Reclassifications:
	Certain reclassifications of previously reported amounts have been made to conform to the current year presentation. Certain overhead expenses and salaries that were previously reported as sales and marketing (“S&M') in the amount of $294 thousand and $608 thousand have been reclassified to cost of revenues in the consolidated statements of income (loss) for the year ended December 31, 2012 and 2013, respectively. Certain outside services expenses that were previously reported as cost of revenues in the amount of $247 thousand and $114 thousand have been reclassified to R&D in the consolidated statements of income (loss) for the year ended December 31, 2012 and 2013, respectively. The Company reviewed the impact of these reclassifications and determined that the reclassifications were not material on the prior year's consolidated financial statements.
Recently issued accounting standards		w.	Recently issued accounting standards:
	In May 2014, the Financial Accounting Standards Board, or FASB, issued an Accounting Standard Update, or ASU, on revenue from contracts with customers, which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance. This ASU, which will be effective for the Company beginning January 1, 2017, allows for either full or modified retrospective methods of adoption and early adoption is not permitted. The Company is currently evaluating the method of adoption, as well as the effect that adoption of this ASU will have on its consolidated financial statements.
	In 2014, the FASB issued ASU 15-2014, Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern, which defines management's responsibility to assess an entity's ability to continue as a going concern, and to provide related footnote disclosures if there is substantial doubt about its ability to continue as a going concern. The pronouncement is effective for annual reporting periods ending after December 15, 2016 with early adoption permitted. The Company is currently evaluating the effect, if any, that the adoption of this guidance will have on its consolidated financial statements.

General_Tables

General (Tables)	12 Months Ended
	Dec. 31, 2014
Frisk Software, Inc. [Member]
Business Acquisition [Line Items]
Schedule of Purchase Price Allocation	Cash and cash equivalents		$	202
	Trade receivables			36
	Prepaid expenses and other receivables			287
	Property and equipment			64
	Intangible assets			2,250
	Goodwill			3,501
	Total assets acquired			6,340
	Trade payables			(571	)
	Deferred revenues			(565	)
	Long-term deferred tax liabilities			(289	)
	Total liabilities assumed			(1,425	)
	Net assets acquired		$	4,915
Schedule of Components Of Intangible Assets With Annual Rates Of Amortization			Fair value			%
	Trademark		$	984			10
	Intellectual property			1,266			6.7
	Total intangible assets		$	2,250
Eleven GMBH [Member]
Business Acquisition [Line Items]
Schedule of Purchase Price Allocation	Cash and cash equivalents		$	3,297
	Trade receivables			846
	Prepaid expenses and other receivables			252
	Property and equipment			449
	Other intangible assets			9,100
	Goodwill			14,732
	Total assets acquired			28,676
	Trade payables			(128	)
	Employees and payroll accruals			(194	)
	Accrued expenses and other liabilities			(2,313	)
	Deferred revenues			(844	)
	Long-term deferred tax liabilities			(2,904	)
	Total liabilities assumed			(6,383	)
	Net assets acquired		$	22,293
Schedule of Components Of Intangible Assets With Annual Rates Of Amortization	(in thousands)		Fair value			%
	Trademark		$	671			10
	Customer relations			3,037			Accelerated method
	Technology			4,611			10
	In-process R&D (*)			781			(*)
	Total intangible assets		$	9,100
		(*)	The in-process research and development ("IPR&D") is amortized when the development is completed. Commencing January 2013, the Company began amortizing a portion of the IPR&D, in the amount of $169 thousand and with an estimated useful life of ten years, related to the development of a specific product which had become available for general release. Commencing January 2014, the Company began amortizing the remainder of the IPR&D, in the amount of $612 thousand and with an estimated useful life of 9 years, related to the development of another specific product which had become available for general release.

Significant_Accounting_Policie2

Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2014
Significant Accounting Policies [Abstract]
Schedule Of Depreciable Life		%
	Computers and peripheral equipment	33.33
	Office furniture and equipment	7.0 – 20.0
	Motor vehicles	15
	Leasehold improvements	Over the shorter of the term of the lease or the life of the assets
Schedule Of Fair Value Assumptions		Year ended
		December 31,
	Stock options	2012	2013	2014
	Volatility	38%-51%	37%-47%	38%-42%
	Risk-free interest rate	0.5%-0.9%	0.5%-1.5%	1.0%-1.7%
	Dividend yield	0%	0%	0%
	Expected term (years)	3.8-4.9	3.5-4.9	3.3-4.9

Property_And_Equipment_Net_Tab

Property And Equipment, Net (Tables)	12 Months Ended
	Dec. 31, 2014
Property And Equipment, Net [Abstract]
Schedule Of Property And Equipment		31-Dec
	(in thousands)	2013			2014
	Cost:
	Computers and peripheral equipment	$	7,350		$	8,160
	Office furniture and equipment		1,112			1,151
	Motor vehicles		10			-
	Leasehold improvements		1,581			1,587
			10,053			10,898
	Less accumulated depreciation		(7,379	)		(8,497	)
	Property and equipment, net	$	2,674		$	2,401

Intangible_Assets_Net_Tables

Intangible Assets, Net (Tables)	12 Months Ended
	Dec. 31, 2014
Intangible Assets, Net [Abstract]
Intangible Assets, Net		December 31,
	(in thousands)	2013			2014
	Original amounts:
	Customer contracts and relationships	$	5,754		$	5,367
	Technology		7,961			8,092
	Trademarks		1,709			1,623
	In-process R&D		674			-
			16,098			15,082
	Accumulated amortization:
	Customer contracts and relationships		(1,378	)		(1,980	)
	Technology		(1,326	)		(2,201	)
	Trademarks		(205	)		(357	)
	Accumulated amortization		(2,909	)		(4,538	)
	Intangible assets, net	$	13,189		$	10,544

Goodwill_Tables

Goodwill (Tables)	12 Months Ended
	Dec. 31, 2014
Goodwill [Abstract]
Changes In Carrying Amount Of Goodwill		Year ended
		December 31,
	(in thousands)	2013		2014
	Balance at the beginning of the year	$	22,518	$	23,206
	Foreign currency translation adjustments		688		(1,881	)
	Balance at the year end	$	23,206	$	21,325

Commitments_And_Contingencies_

Commitments And Contingencies (Tables)	12 Months Ended
	Dec. 31, 2014
Commitments And Contingencies [Abstract]
Schedule Of Annual Minimum Future Lease Payments	2015	$	1,135
	2016		998
	2017		855
	2018		267
		$	3,255

Shareholders_Equity_Tables

Shareholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2014
Shareholders' Equity [Abstract]
Summary Of Employee Share Option Activity		Number of options			Weighted average			Weighted average			Aggregate intrinsic
								remaining			value
					exercise price			contractual term
								(years)
		2013
	Outstanding at January 1, 2014		5,266,487		$	3.02			4.49		$	1,073
	Granted		1,170,002			2.67
	Exercised		-152,181			2.52
	Expired and forfeited		-1,580,629			3.13
	Outstanding at December 31, 2014		4,703,679			2.91			5.16			55
	Options vested and expected to vest at December 31, 2014		4,388,419			2.92			5.11			50
	Exercisable options at December 31, 2014		1,976,892			3.11			4.17			-
	Weighted average fair value of options granted during the year					0.84
Schedule Of Options Outstanding	Outstanding											Exercisable
	Exercise					Weighted average			Weighted average						Weighted average
						remaining			exercise						exercise
	price per		Options			contractual			price per			Options			price per
	share		outstanding			life in years			share			exercisable			share
	$1.56-$2.34			496,669			5.61		$	1.73			26,667	$	2
	$2.44-$2.93			1,702,837			4.39		$	2.68			691,811	$	2.65
	$3.01-$3.14			726,390			4.43		$	3.1			272,699	$	3.11
	$3.16-$3.32			967,116			4.43		$	3.28			252,509	$	3.21
	$3.41-$3.69			661,834			2.39		$	3.47			584,373	$	3.47
	$3.75-$3.94			148,833			1.54		$	3.89			148,833	$	3.89
				4,703,679			4.16		$	2.92			1,976,892	$	3.11
Schedule Of Options To Non-Employees	Issuance date	Options			Exercise price			Options			Exercisable through
		outstanding			per share			exercisable
	16-Feb-12		53,000		$	3.16			36,493		16-Feb
	13-Feb-13		5,000		$	3.14			2,296		19-Feb
	1-Aug-13		150,000		$	3.08			50,000		19-Aug
	14-May-14		3,000		$	3.32			-		20-May
			211,000						88,789
Schedule of Stock-Based Compensation		Year ended
		December 31,
	(in thousands)	2012			2013			2014
	Cost of revenues	$	53		$	50		$	55
	Research and development		231			267			292
	Sales and marketing		200			264			292
	General and administrative		803			763			581
		$	1,287		$	1,344		$	1,220

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2014
Income Taxes [Abstract]
Schedule Of Deferred Income Taxes		December 31,
	(in thousands)	2013					2014
	Deferred tax assets:
	Net operating loss carryforwards	$	48,095				$	47,524
	Capital loss carryforwards		4,842					4,149
	Temporary differences		2,734					2,630
	Deferred tax assets before valuation allowance		55,671					54,303
	Valuation allowance		(55,456		)			(54,128	)
	Deferred tax asset net of valuation allowance		215					175
	Deferred tax liabilities:
	Acquired intangibles		(2,723		)			(2,099	)
	Deferred revenue		(193		)			(167	)
	Deferred tax liability		(2,916		)			(2,266	)
	Deferred tax liability, net	$	(2,701		)		$	(2,091	)
		December 31,
	(in thousands)	2013					2014
	Foreign:
	Current deferred tax asset (liability), net	$	48				$	(120	)
	Non-current deferred tax liability, net		(2,749		)			(1,971	)
		$	(2,701		)		$	(2,091	)
		$	(2,701		)		$	(2,091	)
Schedule Of Income Tax Benefit		Year ended
		December 31,
		2012				2013				2014
	Domestic	$	1,430			$	(3,683	)		$	(5,342	)
	Foreign		(570	)			(968	)			(1,870	)
		$	860			$	(4,651	)		$	(7,212	)
Schedule Of Tax Expense (Benefit)		Year ended
		December 31,
		2012				2013				2014
	Current taxes:
	Foreign	$	(124	)		$	(240	)		$	(122	)
	Domestic		(57	)			-				-
		$	(181	)		$	(240	)		$	(122	)
	Deferred taxes:
	Foreign	$	942			$	(1,065	)		$	318
	Domestic		(136	)			(3,915	)			-
		$	806			$	(4,980	)		$	318
	Tax benefit (expense), net	$	625			$	(5,220	)		$	196
Schedule Of Reconciliation Of The Beginning And Ending Amount Of Unrecognized Tax Benefits Related To Uncertain Tax Positions		December 31,
		2013					2014
	Beginning balance	$	-				$	-
	Increases related to tax positions taken during the current year		-					100
	Ending balance	$	-				$	100

Geographic_Information_Tables

Geographic Information (Tables)	12 Months Ended
	Dec. 31, 2014
Geographic Information [Abstract]
Schedule Of Revenues And Long-Lived Assets From External Customers		Year ended
		December 31,
		2012		2013			2014
	United States	$	11,847	$	12,726		$	11,712
	Germany		2,147		10,321			9,191
	Europe (other than Germany)		3,590		4,086			4,635
	Asia		3,484		2,717			3,600
	Israel		2,541		1,602			1,985
	Other		301		796			802
		$	23,910	$	32,248		$	31,925
		December 31
		2013			2014
	Israel	$	830		$	661
	United States		1,090			1,177
	Germany		622			377
	Other		132			186
		$	2,674		$	2,401

Financial_Income_Expenses_Net_

Financial Income (Expenses), Net (Tables)	12 Months Ended
	Dec. 31, 2014
Financial Income (Expenses), Net [Abstract]
Schedule Of Financial Income (Expenses), Net		Year ended December 31,
		2012			2013			2014
	Income:
	Interest on cash and cash equivalents and short term deposits	$	144		$	3		$	2
	Foreign currency exchange differences, net		169			-			-
			313			3			2
	Expenses:
	Accretion of earn-out consideration		(224	)		(878	)		(299	)
	Interest on bank loans and credit line		-			(197	)		(435	)
	Foreign currency exchange differences, net		-			(124	)		(48	)
	Other		(9	)		(59	)		(94	)
			(233	)		(1,258	)		(876	)
		$	80		$	(1,255	)	$	(874	)

General_Narrative_Details

General (Narrative) (Details) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
General [Line Items]
Number of reportable segments	1
Estimated fair value of earn-out and an additional contingent consideration	$2,269	$1,428
Frisk Software, Inc. [Member]
General [Line Items]
Date of acquisition	1-Oct-12
Purchase price	4,915
Cash paid	2,200
Equity instruments paid	1,678
Additional contingent consideration	351	51
Annual rates of amortization	8.00%
Estimated fair value of earn-out and an additional contingent consideration	456
Change in fair value of earn-out liability	7	397
Frisk Software, Inc. [Member] | Ordinary Shares [Member]
General [Line Items]
Number of shares authorized	750,000
Eleven GMBH [Member]
General [Line Items]
Date of acquisition	16-Nov-12
Purchase price	22,293
Cash paid	11,543
Equity instruments paid	1,832
Additional contingent consideration	0	3,943
Annual rates of amortization	10.00%
Estimated fair value of earn-out and an additional contingent consideration	2,650
Change in fair value of earn-out liability	$737	$2,879
Eleven GMBH [Member] | Ordinary Shares [Member]
General [Line Items]
Number of shares authorized	806,750

General_Purchase_Price_Allocat

General (Purchase Price Allocation) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Business Acquisition [Line Items]
Goodwill	$21,325	$23,206	$22,518
Frisk Software, Inc. [Member]
Business Acquisition [Line Items]
Cash	202
Trade receivables	36
Prepaid expenses and other receivables	287
Property and equipment	64
Intangible assets	2,250
Goodwill	3,501
Total assets acquired	6,340
Trade payables	-571
Deferred revenues	-565
Long-term deferred tax liabilities	-289
Total liabilities assumed	-1,425
Net assets acquired	4,915
Eleven GMBH [Member]
Business Acquisition [Line Items]
Cash	3,297
Trade receivables	846
Prepaid expenses and other receivables	252
Property and equipment	449
Intangible assets	9,100
Goodwill	14,732
Total assets acquired	28,676
Trade payables	-128
Employees and payroll accruals	-194
Accrued expenses and other liabilities	-2,313
Deferred revenues	-844
Long-term deferred tax liabilities	-2,904
Total liabilities assumed	-6,383
Net assets acquired	$22,293

General_Schedule_of_Components

General (Schedule of Components Of Intangible Assets With Annual Rates Of Amortization) (Details) (USD $)	12 Months Ended				1 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013	Dec. 31, 2012	Jan. 31, 2013	Jan. 31, 2014
Acquired Finite-Lived Intangible Assets [Line Items]
Amortization of intangible assets	$1,736		$1,755	$589
Frisk Software, Inc. [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Total intangible assets	2,250
Annual rates of amortization	8.00%
Frisk Software, Inc. [Member] | Trademarks [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Total intangible assets	984
Annual rates of amortization	10.00%
Frisk Software, Inc. [Member] | Intellectual Property [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Total intangible assets	1,266
Annual rates of amortization	6.70%
Eleven GMBH [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Total intangible assets	9,100
Annual rates of amortization	10.00%
Eleven GMBH [Member] | Trademarks [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Total intangible assets	671
Annual rates of amortization	10.00%
Eleven GMBH [Member] | Customer Relations [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Total intangible assets	3,037
Eleven GMBH [Member] | Technology [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Total intangible assets	4,611
Annual rates of amortization	10.00%
Eleven GMBH [Member] | In Process R&D [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Total intangible assets	781
Annual rates of amortization		[1]
Eleven GMBH [Member] | In Process R&D [Member] | Product, one [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Total intangible assets					169
Useful life					10 years
Eleven GMBH [Member] | In Process R&D [Member] | Product, two [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Total intangible assets						$612
Useful life						9 years
[1]	The in-process research and development ("IPR&D") is amortized when the development is completed. Commencing January 2013, the Company began amortizing a portion of the IPR&D, in the amount of $169 thousand and with an estimated useful life of ten years, related to the development of a specific product which had become available for general release. Commencing January 2014, the Company began amortizing the remainder of the IPR&D, in the amount of $612 thousand and with an estimated useful life of 9 years, related to the development of another specific product which had become available for general release.

Significant_Accounting_Policie3

Significant Accounting Policies (Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Significant Accounting Policies [Line Items]
Restricted cash	$118,000
Long-lived assets, impairment losses
Number of operating segments	1
Goodwill impairment
Research and development grants	516,000	505,000	257,000
Allowance for doubtful accounts	759,000	1,070,000
Bad debt expense	-73,000	672,000	456,000
Severance expense (income)	18,000	-105,000	-2,000
Proceeds from sale of investment in affiliate		194,000
Investment in affiliate		0
Loss from sale of investment in affiliate		1,289,000
Anti-dilutive securities	5,837,758	4,864,218	3,156,346
Sales and marketing	11,802,000	10,278,000	5,566,000
Cost of revenues	8,123,000	7,695,000	4,397,000
R&D	11,222,000	9,270,000	6,528,000
Restatement adjustment for overhead expenses and salaries [Member]
Significant Accounting Policies [Line Items]
Sales and marketing		608,000	294,000
Cost of revenues		608,000	294,000
Restatement adjustment for outside services expenses [Member]
Significant Accounting Policies [Line Items]
Cost of revenues		114,000	247,000
R&D		$114,000	$247,000
Minimum [Member]
Significant Accounting Policies [Line Items]
Intangible assets, useful life	7 years
Revenue Recognition Service Term	1 year
Maximum [Member]
Significant Accounting Policies [Line Items]
Intangible assets, useful life	14 years
Revenue Recognition Service Term	3 years

Significant_Accounting_Policie4

Significant Accounting Policies (Schedule Of Depreciable Life) (Details)	12 Months Ended
	Dec. 31, 2014
Computers And Peripheral Equipment [Member]
Property, Plant and Equipment [Line Items]
Depreciation rate	33.33%
Motor Vehicles [Member]
Property, Plant and Equipment [Line Items]
Depreciation rate	15.00%
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Depreciation description	Over the shorter of the term of the lease or the life of the assets
Maximum [Member] | Office Furniture And Equipment [Member]
Property, Plant and Equipment [Line Items]
Depreciation rate	20.00%
Minimum [Member] | Office Furniture And Equipment [Member]
Property, Plant and Equipment [Line Items]
Depreciation rate	7.00%

Significant_Accounting_Policie5

Significant Accounting Policies (Schedule Of Fair Value Assumptions) (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility, minimum	38.00%	37.00%	38.00%
Volatility, maximum	42.00%	47.00%	51.00%
Risk-free interest rate, minimum	1.00%	0.50%	0.50%
Risk-free interest rate, maximum	1.70%	1.50%	0.90%
Dividend yield	0.00%	0.00%	0.00%
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term	3 years 3 months 18 days	3 years 6 months	3 years 9 months 18 days
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term	4 years 10 months 24 days	4 years 10 months 24 days	4 years 10 months 24 days

Property_And_Equipment_Net_Det

Property And Equipment, Net (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Property, Plant and Equipment [Line Items]
Property and Equipment, cost	$10,898	$10,053
Less accumulated depreciation	-8,497	-7,379
Property and Equipment, net	2,401	2,674
Depreciation	1,285	1,136	560
Computers And Peripheral Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and Equipment, cost	8,160	7,350
Office Furniture And Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and Equipment, cost	1,151	1,112
Motor Vehicles [Member]
Property, Plant and Equipment [Line Items]
Property and Equipment, cost		10
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and Equipment, cost	$1,587	$1,581

Intangible_Assets_Net_Details

Intangible Assets, Net (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Finite-Lived Intangible Assets [Line Items]
Original amounts	$15,082	$16,098
Accumulated amortization	-4,538	-2,909
Intangible assets, net	10,544	13,189
Amortization of intangible assets	1,736	1,755	589
Customer Contracts And Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Original amounts	5,367	5,754
Accumulated amortization	-1,980	-1,378
Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Original amounts	8,092	7,961
Accumulated amortization	-2,201	-1,326
Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Original amounts	1,623	1,709
Accumulated amortization	-357	-205
In Process R&D [Member]
Finite-Lived Intangible Assets [Line Items]
Original amounts		$674

Goodwill_Details

Goodwill (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Goodwill [Abstract]
Balance at the beginning of the year	$23,206	$22,518
Foreign currency translation adjustments	-1,881	688
Balance at the year end	$21,325	$23,206

Credit_Line_Details

Credit Line (Details) (USD $)	1 Months Ended	0 Months Ended
	Oct. 21, 2013	Mar. 20, 2015	Dec. 31, 2014
Line of Credit Facility [Line Items]
Borrowing availability	$7,500,000	$6,000,000
Expiration period	1 year
Outstanding borrowings			4,800,000
Minimum [Member]
Line of Credit Facility [Line Items]
Interest rate	6.00%	5.50%
Aggregate amount of interest per month		$18,000

Commitments_And_Contingencies_1

Commitments And Contingencies (Narrative) (Details)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2014	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
	USD ($)	EUR (€)	USD ($)	USD ($)	Eleven GMBH [Member]	Royalties Due to OCS [Member]	Royalties Due to OCS [Member]	Royalties Due to OCS [Member]
					EUR (€)	USD ($)	USD ($)	USD ($)
Aggregate proceeds from participation in governmental R&D grant program	$1,184
Royalty payment rate	3.50%	3.50%	3.50%	3.00%
Percent of grants received paid for by royalties	100.00%	100.00%
Total commitment for royalties payable	897
Cost of revenues	8,123		7,695	4,397		129	78	58
Facilities rent expense	1,056		985	531
Escrow deposit					740
Loss contingency amount of claim related to earn-out liability claimed by entity					1,466
Loss contingency amount of claim related to earn-out liability claimed from entity					781
Legal reserve		€ 275

Commitments_And_Contingencies_2

Commitments And Contingencies (Schedule Of Annual Minimum Future Lease Payments) (Details) (USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified
Commitments And Contingencies [Abstract]
2015	$1,135
2016	998
2017	855
2018	267
Total operating leases	$3,255

Shareholders_Equity_Employee_S

Shareholders' Equity (Employee Stock Options Narrative) (Details) (USD $)	0 Months Ended	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Jul. 30, 2014	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of ordinary shares	4,771,796
Nominal value per share	$0.15
Number of ordinary shares that can be purchased from issuance of warrants	1,670,128
Number of ordinary shares that can be purchased by one warrant	0.35
Offering price per fixed combination	$2.41	$2.41
Exercise price	$3.08
Exercise period	6 months
Expiration period	90 months
Proceeds received	$10,239	$10,239
Issuance expenses	$1,261	$1,261
Employee Stock Options [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period		4 years
Employee Stock Options [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period		6 years
Employee Stock Options [Member] | Awards prior to September, 2005 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options, expiration term		10 years
Employee Stock Options [Member] | Awards after September, 2005 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options, expiration term		6 years
Employee Stock Options [Member] | Amended And Restated Israeli Share Option Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Ordinary shares available for grant		2,088,463

Shareholders_Equity_Directors_

Shareholders' Equity (Directors Stock Options Narrative) (Details) (Employee Stock Options [Member], Directors Stock Option Plan [Member])	12 Months Ended
	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Original allotment of shares	1,263,333
Exercisable rate	6.25%
Exercisable rate, frequency of rate application	every three months
Awards prior to September, 2005 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term	10 years
Awards after September, 2005 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term	6 years

Shareholders_Equity_Options_To

Shareholders' Equity (Options To Non-Employees Narrative) (Details) (Non-employee Stock Options [Member], USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014
Non-employee Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense related to non-vested stock options for non-employees	$32
Period of recognition for unrecognized compensation expense related to non-vested stock options for non-employees	2 years 5 months 5 days

Shareholders_Equity_Summary_Of

Shareholders' Equity (Summary Of Employee Share Option Activity) (Details) (Employees and directors share option [Member], USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Employees and directors share option [Member]
Number of options
Outstanding at the beginning of the year	5,266,487
Granted	1,170,002
Exercised	-152,181
Expired and forfeited	-1,580,629
Outstanding at the end of the year	4,703,679	5,266,487
Options vested and expected to vest at the end of the year	4,388,419
Exercisable options at the end of the year	1,976,892
Weighted average exercise price
Outstanding at the beginning of the year	$3.02
Granted	$2.67
Exercised	$2.52
Expired and forfeited	$3.13
Outstanding at the end of the year	$2.91	$3.02
Options vested and expected to vest at the end of the year	$2.92
Exercisable options at the end of the year	$3.11
Weighted average fair value of options granted during the year	$0.84
Outstanding, Weighted average remaining contractual term	5 years 1 month 28 days	4 years 5 months 26 days
Vested and expected to vest at end of year, Weighted average remaining contractual term	5 years 1 month 10 days
Exercisable, Weighted average remaining contractual term	4 years 2 months 1 day
Aggregate intrinsic value
Outstanding at the beginning of the year	$1,073
Outstanding at the end of the year	55	1,073
Options vested and expected to vest at the end of the year	50
Exercisable options at the end of the year
Unrecognized estimated compensation cost related to non-vested stock options granted	$2,116
Unrecognized compensation cost, recognition period	2 years 8 months 19 days

Shareholders_Equity_Schedule_O

Shareholders' Equity (Schedule Of Options Outstanding) (Details) (Employee Stock Options [Member], USD $)	12 Months Ended
	Dec. 31, 2014
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding	4,703,679
Weighted average remaining contractual life	4 years 1 month 28 days
Weighted average price per share	$2.92
Options exercisable	1,976,892
Weighted average exercise price per share of exercisable options	$3.11
$1.56-$2.34 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price per share, lower limit	$1.56
Exercise price per share, upper limit	$2.34
Options Outstanding	496,669
Weighted average remaining contractual life	5 years 7 months 10 days
Weighted average price per share	$1.73
Options exercisable	26,667
Weighted average exercise price per share of exercisable options	$2
$2.44-$2.93 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price per share, lower limit	$2.44
Exercise price per share, upper limit	$2.93
Options Outstanding	1,702,837
Weighted average remaining contractual life	4 years 4 months 20 days
Weighted average price per share	$2.68
Options exercisable	691,811
Weighted average exercise price per share of exercisable options	$2.65
$3.01-$3.14 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price per share, lower limit	$3.01
Exercise price per share, upper limit	$3.14
Options Outstanding	726,390
Weighted average remaining contractual life	4 years 5 months 5 days
Weighted average price per share	$3.10
Options exercisable	272,699
Weighted average exercise price per share of exercisable options	$3.11
$3.16-$3.32 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price per share, lower limit	$3.16
Exercise price per share, upper limit	$3.32
Options Outstanding	967,116
Weighted average remaining contractual life	4 years 5 months 5 days
Weighted average price per share	$3.28
Options exercisable	252,509
Weighted average exercise price per share of exercisable options	$3.21
$3.41-$3.69 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price per share, lower limit	$3.41
Exercise price per share, upper limit	$3.69
Options Outstanding	661,834
Weighted average remaining contractual life	2 years 4 months 20 days
Weighted average price per share	$3.47
Options exercisable	584,373
Weighted average exercise price per share of exercisable options	$3.47
$3.75-$3.94 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price per share, lower limit	$3.75
Exercise price per share, upper limit	$3.94
Options Outstanding	148,833
Weighted average remaining contractual life	1 year 6 months 14 days
Weighted average price per share	$3.89
Options exercisable	148,833
Weighted average exercise price per share of exercisable options	$3.89

Shareholders_Equity_Schedule_O1

Shareholders' Equity (Schedule Of Options To Non-Employees) (Details) (Non-employee Stock Options [Member], USD $)	0 Months Ended				12 Months Ended
	14-May-14	Aug. 01, 2013	Feb. 13, 2013	Feb. 16, 2012	Dec. 31, 2014
Non-employee Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding	3,000	150,000	5,000	53,000	211,000
Exercise price per share	$3.32	$3.08	$3.14	$3.16
Options exercisable		50,000	2,296	36,493	88,789
Exercisable through	May-20	Aug-19	Feb-19	Feb-16

Shareholders_Equity_Schedule_O2

Shareholders' Equity (Schedule Of Stock-Based Compensation) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Compensation expense	$1,220	$1,344	$1,287
Cost of Revenues [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Compensation expense	55	50	53
Research and Development [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Compensation expense	292	267	231
Selling and Marketing [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Compensation expense	292	264	200
General and Administrative [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Compensation expense	$581	$763	$803

Income_Taxes_Narrative_Details

Income Taxes (Narrative) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Valuation Allowance [Line Items]
Tax rate	26.50%	25.00%	25.00%
Undistributed earnings of foreign subsidiaries that are considered to be permanently reinvested	$1,775
Unrecognized deferred tax liability related to undistributed earnings of foreign subsidiaries	532
Operating loss carryforwards	54,794
Capital loss carryforwards	15,658
U.S. Tax Authority [Member]
Valuation Allowance [Line Items]
Operating loss carryforwards	96,424
Utilization Of Net Operating Loss Carryforwards [Member]
Valuation Allowance [Line Items]
Increase (decrease) in the valuation allowance	-1,700		215
Net Operating Loss Carryforwards Expected To Be Realized In The Foreseeable Future [Member]
Valuation Allowance [Line Items]
Increase (decrease) in the valuation allowance		6,431	-840

Income_Taxes_Schedule_Of_Defer

Income Taxes (Schedule Of Deferred Income Taxes) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Deferred tax assets:
Net operating loss carry-forwards	$47,524	$48,095
Capital loss carry-forwards	4,149	4,842
Temporary differences	2,630	2,734
Deferred tax assets before valuation allowance	54,303	55,671
Valuation allowance	-54,128	-55,456
Deferred tax asset net of valuation allowance	175	215
Deferred tax liabilities:
Acquired intangibles	-2,099	-2,723
Deferred revenue	-167	-193
Deferred tax liabilities	-2,266	-2,916
Deferred tax liability, net	($2,091)	($2,701)

Income_Taxes_Schedule_Of_Defer1

Income Taxes (Schedule Of Deferred Income Taxes Domestic and Foreign) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Deferred Income Tax Assets And Liabilities [Line Items]
Non-current deferred tax liability, net	($1,984)	($2,749)
Deferred tax (liability), net	-2,091	-2,701
Foreign [Member]
Deferred Income Tax Assets And Liabilities [Line Items]
Current deferred tax asset (liability), net	-120	48
Non-current deferred tax liability, net	-1,971	-2,749
Deferred tax (liability), net	($2,091)	($2,701)

Income_Taxes_Schedule_Of_Incom

Income Taxes (Schedule Of Income Tax Benefit) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Taxes [Abstract]
Domestic	($5,342)	($3,683)	$1,430
Foreign	-1,870	-968	-570
Income (loss) before taxes on income	($7,212)	($4,651)	$860

Income_Taxes_Schedule_Of_Tax_E

Income Taxes (Schedule Of Tax Expense (Benefit)) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Current taxes:
Foreign	($122)	($240)	($124)
Domestic			-57
Total current income taxes	-122	-240	-181
Deferred taxes:
Foreign	318	-1,065	942
Domestic		-3,915	-136
Total deferred taxes	318	-4,980	806
Tax benefit (expense)	$196	($5,220)	$625

Income_Taxes_Schedule_Of_Recon

Income Taxes (Schedule Of Reconciliation Of Unrecognized Tax Benefits Related To Uncertain Tax Positions) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
A reconciliation of the beginning and ending amount of unrecognized tax benefits related to uncertain tax positions
Beginning balance
Increases related to tax positions taken during the current year	100
Ending balance	$100

Geographic_Information_Narrati

Geographic Information (Narrative) (Details)	12 Months Ended
	Dec. 31, 2014
Geographic Information [Abstract]
Number of reportable segments	1
Number Of Major Customers	0

Geographic_Information_Schedul

Geographic Information (Schedule Of Revenues And Long-Lived Assets From External Customers) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$31,925	$32,248	$23,910
Long-lived assets	2,401	2,674
United States [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	11,712	12,726	11,847
Long-lived assets	1,177	1,090
Germany [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	9,191	10,321	2,147
Long-lived assets	377	622
Europe (other than Germany) [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	4,635	4,086	3,590
Asia [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	3,600	2,717	3,484
Israel [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	1,985	1,602	2,541
Long-lived assets	661	830
Other [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	802	796	301
Long-lived assets	$186	$132

Financial_Income_Expenses_Net_1

Financial Income (Expenses), Net (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income:
Interest on cash and cash equivalents and short term deposit	$2	$3	$144
Foreign currency exchange differences, net			169
Total financial income	2	3	313
Expenses:
Accretion of earn-out consideration	-299	-878	-224
Interest on bank loans and credit line	-435	-197
Foreign currency exchange differences, net	-48	-124
Other	-94	-59	-9
Total financial expenses	-876	-1,258	-233
Financial (expenses) income, net	($874)	($1,255)	$80